SeqOnce BioSciences Inc., a biotech startup based in Pasadena, has raised $1 million in its latest financing round, according to securities filings.
A state physician’s group has come out against a proposed ballot measure that would limit the cost of kidney dialysis, saying it would put patients’ lives at risk.
The downtown-based multi-level marketing firm Herbalife Ltd. has a new name: Herbalife Nutrition Ltd.
Science 37 Inc., a mobile tech and clinical trial firm based in Playa Vista, has struck a deal with Logical Images Inc. to help doctors and patients better manage skin disorders, the companies announced April 24.
The National Health Foundation is set to transform a century-old sanitarium into a 62-bed recuperative-care facility in Pico-Union for homeless residents discharged from local hospitals.
Herbalife Ltd., a global health nutrition company based downtown, on April 18 announced a self-tender offer to buy back up to $600 million worth of shares.
82 Labs Inc., a health care startup based in Koreatown with a hangover remedy drink, has closed a stock offering for $10 million, according to a securities filing.
Avenda Health Inc., a biomedical device company based in Santa Monica, has closed a funding round of $3.3 million, according to a securities filing released April 11.
Biomedical researchers across Los Angeles County received $1 billion in federal research funding last year – a $105 million increase over 2016, according to a report released by Biocom L.A.
Puma Biotechnology Inc., based in Westwood, has struck an up-to-$35-million deal with Pint Pharma International to commercialize its signature cancer drug in Latin America.
Apollo Medical Holdings Inc., a health care management firm based in Glendale, had a 17-percent boost in revenue last year after its year-long merger with Network Medical Management Inc., the company announced April 3.
Nanotech Energy Inc., a West Los Angeles company that produces microscopic supercapacitors for smartphones and biomedical devices, on April 3 raised more than $3 million in investment funding.
Two UCLA biotech executives, whose Kite Pharma Inc. sold last year for $12 billion, have launched a new venture with Pfizer Inc. to develop a lower-cost immune cell therapy to treat cancer, the company announced April 3.
Providence Tarzana Medical Center’s $542 million expansion, dubbed the “Reimagined Project,” has been greenlit by the Los Angeles City Council, the hospital announced.
City of Hope, the research and treatment center for cancer and diabetes, has added nine radiation oncology sites to its growing clinical network across Southern California, the hospital announced April 2.